Cargando…

Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam(2)Cys

Immunostimulatory agents provide a new category of anti-microbial agents that activate the host’s innate immune system allowing control of viral and/or bacterial infections. The TLR-2 agonist PEG-Pam(2)Cys has been shown to mediate potent anti-viral activity against influenza viruses when administer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mifsud, Edin Jessica, Tan, Amabel C. L., Brown, Lorena Elizabeth, Chua, Brendon Yew Loong, Jackson, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457020/ https://www.ncbi.nlm.nih.gov/pubmed/26097481 http://dx.doi.org/10.3389/fimmu.2015.00290

Ejemplares similares

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014)

Effects of the TLR2 Agonists MALP-2 and Pam(3)Cys in Isolated Mouse Lungs
por: Barrenschee, Martina, et al.
Publicado: (2010)

The Toll-Like Receptor 2 agonist PEG-Pam(2)Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
por: Ernest, Medard, et al.
Publicado: (2018)

An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018)

Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice
por: Huang, Lu, et al.
Publicado: (2015)

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity
por: Chua, Brendon Y., et al.
Publicado: (2015)

Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
por: Chua, Brendon Y., et al.
Publicado: (2012)

Toll like-receptor agonist Pam(3)Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56
por: Kennerknecht, Kathrin, et al.
Publicado: (2020)

Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4
por: Chen, Yi-Guo, et al.
Publicado: (2016)

Targeting Toll-Like Receptor 2: Polarization of Porcine Macrophages by a Mycoplasma-Derived Pam2cys Lipopeptide
por: Franzoni, Giulia, et al.
Publicado: (2021)

Expression of TMPRSS2 is up-regulated by bacterial flagellin, LPS, and Pam3Cys in human airway cells
por: Schwerdtner, Marie, et al.
Publicado: (2023)

Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam(1)CSK(4) and Pam(3)CSK(4)
por: Megy, Simon, et al.
Publicado: (2020)

Principles of agonist recognition in Cys-loop receptors
por: Lynagh, Timothy, et al.
Publicado: (2014)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs
por: Martínez-Orellana, Pamela, et al.
Publicado: (2017)

Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract
por: Mifsud, Edin J., et al.
Publicado: (2021)

Nucleic acid ligands act as a PAM and agonist depending on the intrinsic ligand binding state of P2RY2
por: Takahashi, Masaki, et al.
Publicado: (2021)

Spacer2PAM: A computational framework to guide experimental determination of functional CRISPR-Cas system PAM sequences
por: Rybnicky, Grant A, et al.
Publicado: (2022)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
por: Mangas, Kirstie M., et al.
Publicado: (2020)

Sulforaphane suppresses lipopolysaccharide‐ and Pam3CysSerLys4‐mediated inflammation in chronic obstructive pulmonary disease via toll‐like receptors
por: Zeng, Xiaoli, et al.
Publicado: (2021)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Epidemiology of repeat influenza infection in Queensland, Australia, 2005–2017
por: Price, Olivia, et al.
Publicado: (2022)

GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent
por: Pachanski, Michele J., et al.
Publicado: (2017)

The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
por: Halliday, Alice, et al.
Publicado: (2016)

Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
por: Rasheed, Zahirrah B. M., et al.
Publicado: (2020)

Cys–Cys and Cys–Lys Stapling of Unprotected Peptides Enabled by Hypervalent Iodine Reagents
por: Ceballos, Javier, et al.
Publicado: (2021)

Expression of cysLT1 and cysLT2 Receptor in Chronic Hyperplastic Eosinophilic Sinusitis
por: Ouyang, Yuhui, et al.
Publicado: (2009)

Binding of the kringle‐2 domain of human plasminogen to streptococcal PAM‐type M‐protein causes dissociation of PAM dimers
por: Ayinuola, Olawole, et al.
Publicado: (2021)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
por: Koszalka, Paulina, et al.
Publicado: (2020)

Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets
por: Mifsud, Edin J, et al.
Publicado: (2022)

The LEPSIS Pam-File
por: DELPHI Collaboration
Publicado: (1982)

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
por: Proud, Pamela C., et al.
Publicado: (2020)

Redox properties of Cys(2)His(2) and Cys(4) zinc fingers determined by electrospray ionization mass spectrometry
por: Smirnova, Julia, et al.
Publicado: (2018)

Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis
por: Karlis, Gerasimos D., et al.
Publicado: (2020)

Correction to ‘Spacer2PAM: A computational framework to guide experimental determination of functional CRISPR-Cas system PAM sequences’
Publicado: (2023)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

The interactome of 2-Cys peroxiredoxins in Plasmodium falciparum
por: Brandstaedter, Christina, et al.
Publicado: (2019)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2fai2n3je49jfv16vmunbtrbrh